Skip to content

Zydus Life shares rise as US arm gains rights for rare paediatric disease drug

Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease

Read More

​ Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish